Open Access Green as soon as Postprint is submitted to ZB.
Heterogeneity of HER2 expression in gastric cancer (GC) leads to high deviation rates between local and central testing and hampers efficacy of anti-HER2 therapy: Survival results from the VARIANZ study.
Cancer Res. 78 (2018)
Edit extra informations Login
Publication type Article: Journal article
Document type Meeting abstract
ISSN (print) / ISBN 0008-5472
Journal Cancer Research
Quellenangaben Volume: 78, Issue: 13
Publisher American Association for Cancer Research (AACR)
Publishing Place Philadelphia, Pa.
Reviewing status Peer reviewed
Institute(s) Institute of Computational Biology (ICB)